Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: GMP violations

NMPA GMP and the Manufacture of Biologics

Posted on December 31, 2024 By digi

NMPA GMP and the Manufacture of Biologics NMPA GMP and the Manufacture of Biologics Introduction to NMPA GMP and Biologics Biologics are a rapidly growing segment of the pharmaceutical industry, encompassing a wide range of products, from vaccines and blood products to monoclonal antibodies and gene therapies. Given their complexity and the critical role they…

Read More “NMPA GMP and the Manufacture of Biologics” »

NMPA GMP Guidelines

How ANVISA GMP Regulations Influence the Production of Vaccines

Posted on December 31, 2024 By digi

How ANVISA GMP Regulations Influence the Production of Vaccines How ANVISA GMP Regulations Influence the Production of Vaccines Introduction to ANVISA and Vaccine Manufacturing Vaccines are one of the most important tools in global public health, preventing the spread of infectious diseases and saving millions of lives worldwide. The production of vaccines is a complex…

Read More “How ANVISA GMP Regulations Influence the Production of Vaccines” »

GMP in Latin America (ANVISA, COFEPRIS)

Best Practices for Preparing for TGA GMP Inspections and Audits

Posted on December 31, 2024 By digi

Best Practices for Preparing for TGA GMP Inspections and Audits Effective Strategies for TGA GMP Inspection and Audit Readiness Introduction to TGA GMP Inspections and Audits The Therapeutic Goods Administration (TGA) conducts rigorous Good Manufacturing Practices (GMP) inspections and audits to ensure that pharmaceutical companies comply with Australian quality, safety, and efficacy standards. These inspections…

Read More “Best Practices for Preparing for TGA GMP Inspections and Audits” »

TGA GMP Guidelines

How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs

Posted on December 31, 2024 By digi

How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs Preventing Counterfeit Drugs with Schedule M (Revised) GMP Guidelines Introduction to Counterfeit Drugs and Their Risks Counterfeit drugs pose a serious threat to public health and the pharmaceutical industry. These illegal products, which mimic legitimate medicines, often lack active ingredients, contain harmful substances,…

Read More “How Schedule M (Revised) GMP Helps Prevent the Production of Counterfeit Drugs” »

SCHEDULE - M - Revised

PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products

Posted on December 31, 2024 By digi

PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products Introduction to PMDA GMP and Biopharmaceutical Manufacturing Biopharmaceutical products, including biologics, vaccines, and gene therapies, are becoming increasingly important in the treatment of a wide range of diseases. These products are often more complex to manufacture than…

Read More “PMDA GMP Guidelines for the Manufacture of Biopharmaceutical Products” »

PMDA GMP Guidelines

The Role of WHO GMP in Promoting Good Manufacturing Practices in Global Pharma

Posted on December 31, 2024 By digi

The Role of WHO GMP in Promoting Good Manufacturing Practices in Global Pharma Advancing Global Pharmaceutical Standards with WHO GMP Guidelines Introduction to WHO GMP and Its Global Impact The World Health Organization (WHO)’s Good Manufacturing Practices (GMP)) guidelines play a pivotal role in shaping the global pharmaceutical industry. By establishing standardized protocols for manufacturing,…

Read More “The Role of WHO GMP in Promoting Good Manufacturing Practices in Global Pharma” »

WHO GMP Guidelines

MHRA GMP Compliance and Its Impact on the UK Pharma Market

Posted on December 31, 2024 By digi

MHRA GMP Compliance and Its Impact on the UK Pharma Market The Role of MHRA GMP Compliance in Shaping the UK Pharmaceutical Market Introduction to MHRA GMP Compliance The United Kingdom’s pharmaceutical industry operates within one of the most stringent regulatory frameworks globally, with the Medicines and Healthcare products Regulatory Agency (MHRA) overseeing the enforcement…

Read More “MHRA GMP Compliance and Its Impact on the UK Pharma Market” »

MHRA GMP Guidelines

How NMPA GMP Promotes Drug Safety and Quality Control

Posted on December 30, 2024 By digi

How NMPA GMP Promotes Drug Safety and Quality Control How NMPA GMP Promotes Drug Safety and Quality Control Introduction to NMPA GMP and Drug Safety In the pharmaceutical industry, ensuring the safety and quality of drugs is paramount to protecting public health. The National Medical Products Administration (NMPA), formerly known as the China Food and…

Read More “How NMPA GMP Promotes Drug Safety and Quality Control” »

NMPA GMP Guidelines

TGA GMP and the Role of Technology in Pharmaceutical Manufacturing

Posted on December 30, 2024 By digi

TGA GMP and the Role of Technology in Pharmaceutical Manufacturing How Technology Enhances TGA GMP Compliance in Pharmaceutical Manufacturing Introduction to TGA GMP and Technology The Therapeutic Goods Administration (TGA) enforces Good Manufacturing Practices (GMP) in Australia to ensure the safety, quality, and efficacy of pharmaceutical products. As the pharmaceutical industry evolves, technology plays an…

Read More “TGA GMP and the Role of Technology in Pharmaceutical Manufacturing” »

TGA GMP Guidelines

How COFEPRIS GMP Ensures the Quality of Biological Drugs

Posted on December 30, 2024 By digi

How COFEPRIS GMP Ensures the Quality of Biological Drugs How COFEPRIS GMP Ensures the Quality of Biological Drugs Introduction to Biological Drugs and COFEPRIS GMP Biological drugs, also known as biologics, are a class of pharmaceuticals derived from living organisms or their components. These drugs, which include vaccines, monoclonal antibodies, gene therapies, and cell therapies,…

Read More “How COFEPRIS GMP Ensures the Quality of Biological Drugs” »

GMP in Latin America (ANVISA, COFEPRIS)

Posts pagination

Previous 1 … 15 16 17 … 50 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog

GMP violations

  • How to Meet Health Canada GMP Requirements for Pharmaceutical Packaging and Distribution
  • Health Canada GMP Compliance and Its Impact on Global Pharma Manufacturing
  • How FDA GMP Guidelines Shape the Future of Pharmaceutical Manufacturing
  • How Health Canada GMP Regulations Promote Drug Safety and Efficacy
  • Best Practices for Preparing for FDA GMP Inspections in Pharmaceutical Facilities
  • How Health Canada GMP Helps with Regulatory Inspections in Canada
  • How to Use FDA GMP Compliance to Improve Operational Efficiency
  • How Health Canada GMP Helps with Regulatory Inspections in Canada
  • How FDA GMP Regulations Address Packaging and Labeling Compliance
  • How Health Canada GMP Standards Support Pharmaceutical Product Development

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme